Corona epidemic global drug availability, US company important announcement

Corona epidemic global drug availability, US company important announcement

The Corona virus drug company has taken significant steps to supply the drug to 105 developing countries.

According to foreign media, Corona’s pharmaceutical company Merck has entered into agreements with more than two dozen generic drug companies, with which it will develop a drug called Molnioperavir.

- Advertisement -

It should be noted that Molnioperavir has been developed by Merck in association with Ridgeback Biotherapeutics.

The drug has also been approved for use in EU member states and the United States, which reduces the risk of hospitalization by up to 50%.

According to the agency, 27 companies from 11 countries will soon start developing Merck code medicine.

Pfizer and the MPP said the 95 countries covered by the agreement make up 53 percent of the world’s population, including poor, low-income middle-class and some high-income middle-class countries.

Following the agreement, other countries will be able to develop the drug under a licensing agreement with the International Public Health Group Medicine Patient Pool (MPP).

Charles Gore, MPP’s executive director, said he hoped the generic version would be readily available in the next few months.

Comments

RELATED ARTICLES
- Advertisment -

Most Popular

- Advertisment -